Peter George

Company: Brainomix Ltd.

Job title: Senior Medical Director


Brainomix e-Lung Biomarkers are Prognostic & Outperform FVC in the Serial Assessment of Patients with Fibrotic Lung Disease 11:45 am

• FVC as the ‘gold’ standard clinical trial endpoint is variable and may in insensitive to treatment efficacy • Brainomix e-Lung biomarkers provide robust assessment of serial change and have been validated in both IPF and nonIPF cohorts • Imaging biomarkers may hold the key to successful delivery of the next generation of ILD clinical…Read more

day: Day One Track B AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.